These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 21375556)
21. Complementary role of CD4+CD25+ regulatory T cells and TGF-beta in oral tolerance. Chung Y; Lee SH; Kim DH; Kang CY J Leukoc Biol; 2005 Jun; 77(6):906-13. PubMed ID: 15758078 [TBL] [Abstract][Full Text] [Related]
22. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells. Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040 [TBL] [Abstract][Full Text] [Related]
23. Regulatory function for murine intraepithelial lymphocytes. Two subsets of CD3+, T cell receptor-1+ intraepithelial lymphocyte T cells abrogate oral tolerance. Fujihashi K; Taguchi T; McGhee JR; Eldridge JH; Bruce MG; Green DR; Singh B; Kiyono H J Immunol; 1990 Oct; 145(7):2010-9. PubMed ID: 1975820 [TBL] [Abstract][Full Text] [Related]
24. Antigen-specific and non-specific CD4+ T cell recruitment and proliferation during influenza infection. Chapman TJ; Castrucci MR; Padrick RC; Bradley LM; Topham DJ Virology; 2005 Sep; 340(2):296-306. PubMed ID: 16054188 [TBL] [Abstract][Full Text] [Related]
25. A polyclonal anti-vaccine CD4 T cell response detected with HLA-DP4 multimers in a melanoma patient vaccinated with MAGE-3.DP4-peptide-pulsed dendritic cells. Zhang Y; Renkvist N; Sun Z; Schuler-Thurner B; Glaichenhaus N; Schuler G; Boon T; van der Bruggen P; Colau D Eur J Immunol; 2005 Apr; 35(4):1066-75. PubMed ID: 15756643 [TBL] [Abstract][Full Text] [Related]
26. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes. Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515 [TBL] [Abstract][Full Text] [Related]
27. Melanoma antigens recognised by CD8+ and CD4+ T cells. Storkus WJ; Zarour HM Forum (Genova); 2000; 10(3):256-70. PubMed ID: 11007933 [TBL] [Abstract][Full Text] [Related]
28. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination. Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754 [TBL] [Abstract][Full Text] [Related]
30. Aspergillus fumigatus extract differentially regulates antigen-specific CD4+ and CD8+ T cell responses to promote host immunity. Tao J; Segal BH; Eppolito C; Li Q; Dennis CG; Youn R; Shrikant PA J Leukoc Biol; 2006 Sep; 80(3):529-37. PubMed ID: 16793916 [TBL] [Abstract][Full Text] [Related]
31. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions. Sun JB; Cuburu N; Blomquist M; Li BL; Czerkinsky C; Holmgren J Scand J Immunol; 2006 Sep; 64(3):251-9. PubMed ID: 16918694 [TBL] [Abstract][Full Text] [Related]
32. Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system. Na SY; Cao Y; Toben C; Nitschke L; Stadelmann C; Gold R; Schimpl A; Hünig T Brain; 2008 Sep; 131(Pt 9):2353-65. PubMed ID: 18669487 [TBL] [Abstract][Full Text] [Related]
33. MHC class II-restricted tumor antigens recognized by CD4+ T cells: new strategies for cancer vaccine design. Zeng G J Immunother; 2001; 24(3):195-204. PubMed ID: 11394496 [TBL] [Abstract][Full Text] [Related]
34. Breaking B-cell tolerance and CTL tolerance in three OVA-transgenic mouse strains expressing different levels of OVA. Steinaa L; Rasmussen PB; Gautam A; Mouritsen S Scand J Immunol; 2008 Feb; 67(2):113-20. PubMed ID: 18201366 [TBL] [Abstract][Full Text] [Related]
35. Induction of systemic tolerance in normal but not in transgenic mice through continuous feeding of ovalbumin. Simioni PU; Fernandes LG; Gabriel DL; Tamashiro WM Scand J Immunol; 2004 Sep; 60(3):257-66. PubMed ID: 15320882 [TBL] [Abstract][Full Text] [Related]
36. MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyte. Nishimura MI; Avichezer D; Custer MC; Lee CS; Chen C; Parkhurst MR; Diamond RA; Robbins PF; Schwartzentruber DJ; Rosenberg SA Cancer Res; 1999 Dec; 59(24):6230-8. PubMed ID: 10626817 [TBL] [Abstract][Full Text] [Related]
37. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation. Gieni RS; Yang X; Kelso A; Hayglass KT Immunology; 1996 Jan; 87(1):119-26. PubMed ID: 8666423 [TBL] [Abstract][Full Text] [Related]
38. Tumor antigen-specific FOXP3+ CD4 T cells identified in human metastatic melanoma: peptide vaccination results in selective expansion of Th1-like counterparts. Jandus C; Bioley G; Dojcinovic D; Derré L; Baitsch L; Wieckowski S; Rufer N; Kwok WW; Tiercy JM; Luescher IF; Speiser DE; Romero P Cancer Res; 2009 Oct; 69(20):8085-93. PubMed ID: 19808957 [TBL] [Abstract][Full Text] [Related]
39. A transgenic mouse strain with antigen-specific T cells (RAG1KO/sf/OVA) demonstrates that the scurfy (sf) mutation causes a defect in T-cell tolerization. Zahorsky-Reeves JL; Wilkinson JE Comp Med; 2002 Feb; 52(1):58-62. PubMed ID: 11900414 [TBL] [Abstract][Full Text] [Related]
40. Maternal CD4⁺ and CD8⁺ T cell tolerance towards a fetal minor histocompatibility antigen in T cell receptor transgenic mice. Perchellet AL; Jasti S; Petroff MG Biol Reprod; 2013 Oct; 89(4):102. PubMed ID: 24025737 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]